Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyeong Hee Hong

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|April 19, 2022
Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitorsMyeong Joon Kim, Kyeong Hee Hong, Bo Ryeong Lee, et al.
Chembiochem : a European Journal of Chemical Biology|March 8, 2026
Identification of Novel Oxazolo[5,4-d]pyrimidines as IL-33 Inhibitors for Immuno-Oncology TherapyYounghoon Kim, Kyeong Hee Hong, Minjoo Ko, et al.
Nature Immunology|December 28, 2022
Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cellsMyeong Joon Kim, Kyungsoo Kim, Hyo Jin Park, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 6, 2024
Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environmentSusam Lee, Kyeong Hee Hong, Heewon Park, et al.
Biomaterials|June 2, 2026
Helical quaternary amine polypeptide programs membrane stress to drive immunogenic cell death and cytosolic gene delivery for cancer immunotherapySusam Lee, Ao Jiao, Heewon Park, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|April 19, 2022
Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitorsMyeong Joon Kim, Kyeong Hee Hong, Bo Ryeong Lee, et al.
Chembiochem : a European Journal of Chemical Biology|March 8, 2026
Identification of Novel Oxazolo[5,4-d]pyrimidines as IL-33 Inhibitors for Immuno-Oncology TherapyYounghoon Kim, Kyeong Hee Hong, Minjoo Ko, et al.
Nature Immunology|December 28, 2022
Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cellsMyeong Joon Kim, Kyungsoo Kim, Hyo Jin Park, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 6, 2024
Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environmentSusam Lee, Kyeong Hee Hong, Heewon Park, et al.
Biomaterials|June 2, 2026
Helical quaternary amine polypeptide programs membrane stress to drive immunogenic cell death and cytosolic gene delivery for cancer immunotherapySusam Lee, Ao Jiao, Heewon Park, et al.
Pageof 1